Search

everythinglearnresearchcommunity

for

Search:↓

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Recognizing rare causes of MASLD is crucial for effective treatment and preventing complications.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Androgen levels do not determine the type of PCOS symptoms in young females.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Melatonin may help treat PCOS symptoms in rats.

Topical antiandrogens might treat skin issues like hair growth, balding, and acne, but finding effective treatments without side effects is challenging.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Lower irisin levels in the blood may indicate more severe acne.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.